Vaginal Drug Delivery Had A Funding Problem—Merck Changed That [Yahoo! Finance]
Goldman Sachs Group, Inc. (The) (GS)
Last goldman sachs group, inc. (the) earnings: 4/15 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
goldmansachs.com/investor-relations
Company Research
Source: Yahoo! Finance
Calla Lily Clinical Care is developing Callavid to improve how vaginal therapeutics are delivered for IVF, miscarriage prevention, and beyond. Picture the pitch room. Dr. Lara Zibners has a question for the male-majority audience. "How many of you have put medication up your nose?" A few hands go up. Then: "…besides cocaine." Laughter. Then the turn: if nasal drugs leaked the way vaginal drugs do, one of them would have solved it decades ago. It is a joke that lands because it is also a market analysis. Zibners is a board-certified pediatric emergency physician, published author, and national trauma educator at the Royal College of Surgeons who returned to business school at nearly 50 to learn the language she had been missing. Her company, Calla Lily Clinical Care, makes Callavid—a tampon-shaped, leak-resistant vaginal drug delivery platform now in clinical trials for IVF luteal phase support and miscarriage prevention. In February 2026, Merck announced a strategic collaborati
Show less
Read more
Impact Snapshot
Event Time:
GS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GS alerts
High impacting Goldman Sachs Group, Inc. (The) news events
Weekly update
A roundup of the hottest topics
GS
News
- How The SLB (SLB) Story Is Shifting As Analysts Rework Targets And Risks [Yahoo! Finance]Yahoo! Finance
- Goldman Sachs Bullish on 3 Energy Dividend Stocks Into Q1 Earnings [Yahoo! Finance]Yahoo! Finance
- Why The Global Head Of Human Capital Management At Goldman Sachs Says ‘EQ Is The Secret Sauce' In The AI Era [Yahoo! Finance]Yahoo! Finance
- Here's the stealthy reason stocks are at record highs [Yahoo! Finance Canada]Yahoo! Finance Canada
- Here's the stealthy reason stocks are at record highs [Yahoo! Finance]Yahoo! Finance
GS
Earnings
- 4/14/26 - Beat
GS
Sec Filings
- 4/20/26 - Form 424B2
- 4/20/26 - Form 424B2
- 4/20/26 - Form 424B2
- GS's page on the SEC website